Current Ratio
since 2005
Calculation
Eli Lilly & Co., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2023 | 0.94 | = | 25,727,000) | ÷ | 27,293,200) |
| Dec 31, 2022 | 1.05 | = | 18,034,500) | ÷ | 17,138,200) |
| Dec 31, 2021 | 1.23 | = | 18,452,400) | ÷ | 15,052,700) |
| Dec 31, 2020 | 1.40 | = | 17,462,100) | ÷ | 12,481,600) |
| Dec 31, 2019 | 1.16 | = | 13,709,600) | ÷ | 11,775,200) |
| Dec 31, 2018 | 1.73 | = | 20,549,600) | ÷ | 11,888,100) |
| Dec 31, 2017 | 1.32 | = | 19,202,100) | ÷ | 14,535,900) |
| Dec 31, 2016 | 1.37 | = | 15,101,400) | ÷ | 10,986,600) |
| Dec 31, 2015 | 1.53 | = | 12,573,600) | ÷ | 8,229,600) |
| Dec 31, 2014 | 1.09 | = | 12,179,800) | ÷ | 11,207,500) |
| Dec 31, 2013 | 1.47 | = | 13,104,700) | ÷ | 8,916,600) |
| Dec 31, 2012 | 1.55 | = | 13,038,700) | ÷ | 8,389,500) |
| Dec 31, 2011 | 1.60 | = | 14,248,200) | ÷ | 8,930,900) |
| Dec 31, 2010 | 2.09 | = | 14,840,000) | ÷ | 7,101,400) |
| Dec 31, 2009 | 1.90 | = | 12,486,500) | ÷ | 6,568,100) |
| Dec 31, 2008 | 0.95 | = | 12,453,300) | ÷ | 13,109,700) |
| Dec 31, 2007 | 2.33 | = | 12,256,900) | ÷ | 5,268,300) |
| Dec 31, 2006 | 1.91 | = | 9,694,400) | ÷ | 5,085,500) |
| Dec 31, 2005 | 1.89 | = | 10,795,800) | ÷ | 5,716,300) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
Comparison to Competitors
Eli Lilly & Co., current ratio, long-term trends, comparison to competitors
| Eli Lilly & Co. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 0.94 | 0.87 | 1.65 | 1.43 | 1.68 | 1.43 | 1.16 | 1.25 | 0.91 | 5.69 | 1.75 | 3.99 |
| Dec 31, 2022 | 1.05 | 0.96 | 1.41 | 1.25 | 1.89 | 1.29 | 0.99 | 1.47 | 1.22 | 5.06 | 1.48 | 4.83 |
| Dec 31, 2021 | 1.23 | 0.79 | 1.59 | 1.52 | 1.43 | 1.27 | 1.35 | 1.27 | 1.40 | 3.56 | 1.50 | 4.46 |
| Dec 31, 2020 | 1.40 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.21 | 1.02 | 1.35 | 3.63 | 2.13 | 4.33 |
| Dec 31, 2019 | 1.16 | 3.18 | 1.44 | 1.60 | 5.19 | 3.10 | 1.26 | 1.24 | 0.88 | 3.67 | 1.92 | 3.61 |
| Dec 31, 2018 | 1.73 | 0.98 | 2.79 | 1.61 | 1.47 | 3.38 | 1.47 | 1.17 | 1.57 | 4.47 | 1.73 | 3.43 |
| Dec 31, 2017 | 1.32 | 1.28 | 5.49 | 1.55 | 1.43 | 2.74 | 1.41 | 1.33 | 1.35 | 3.82 | 1.34 | 3.28 |
| Dec 31, 2016 | 1.37 | 1.65 | 4.11 | 1.55 | 0.97 | 2.22 | 2.47 | 1.78 | 1.25 | 2.56 | 1.44 | 2.31 |
| Dec 31, 2015 | 1.53 | 1.50 | 4.44 | 1.30 | 1.27 | 2.50 | 2.17 | 1.55 | 1.49 | 3.59 | 1.38 | 2.78 |
| Dec 31, 2014 | 1.09 | 1.41 | 4.95 | 1.73 | 1.75 | 3.07 | 2.36 | 1.77 | 2.67 | 3.31 | 1.22 | 4.20 |
| Dec 31, 2013 | 1.47 | 2.59 | 3.44 | 1.52 | 2.01 | 1.15 | 2.20 | 2.00 | 2.41 | 6.01 | 3.16 | 3.99 |
| Dec 31, 2012 | 1.55 | 2.27 | 3.81 | 1.15 | 1.80 | 1.44 | 1.90 | 1.90 | 2.15 | 7.37 | 2.31 | 3.67 |
| Dec 31, 2011 | 1.60 | — | 4.80 | 1.97 | 1.50 | 5.53 | 2.38 | 2.04 | 2.06 | 4.40 | 1.55 | 3.39 |
| Dec 31, 2010 | 2.09 | — | 3.52 | 1.97 | 1.73 | 2.32 | 2.05 | 1.86 | 2.11 | 3.28 | 2.42 | 2.23 |
| Dec 31, 2009 | 1.90 | — | 4.89 | 2.21 | 1.89 | 2.57 | 1.82 | 1.80 | 1.66 | 4.55 | 2.76 | 4.59 |
| Dec 31, 2008 | 0.95 | — | 3.12 | 2.20 | 1.53 | 3.52 | 1.65 | 1.35 | 1.59 | 6.23 | 2.82 | 4.01 |
| Dec 31, 2007 | 2.33 | — | 2.11 | 1.20 | 1.40 | 4.11 | 1.51 | 1.23 | 2.15 | 2.81 | 1.93 | 2.49 |
| Dec 31, 2006 | 1.91 | — | 1.67 | 1.59 | 1.38 | 3.18 | 1.20 | 1.20 | 2.20 | 10.44 | 1.70 | 3.07 |
| Dec 31, 2005 | 1.89 | — | 2.57 | 1.78 | 1.30 | 6.79 | 2.48 | 1.58 | 1.47 | 8.46 | 1.71 | 3.84 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Eli Lilly & Co., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Eli Lilly & Co. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2023 | 0.94 | 1.27 |
| Dec 31, 2022 | 1.05 | 1.30 |
| Dec 31, 2021 | 1.23 | 1.36 |
| Dec 31, 2020 | 1.40 | 1.37 |
| Dec 31, 2019 | 1.16 | 1.66 |
| Dec 31, 2018 | 1.73 | 1.71 |
| Dec 31, 2017 | 1.32 | 1.74 |
| Dec 31, 2016 | 1.37 | 1.91 |
| Dec 31, 2015 | 1.53 | 1.90 |
| Dec 31, 2014 | 1.09 | 2.19 |
| Dec 31, 2013 | 1.47 | 2.17 |
| Dec 31, 2012 | 1.55 | 2.04 |
| Dec 31, 2011 | 1.60 | 2.30 |
| Dec 31, 2010 | 2.09 | 2.14 |
| Dec 31, 2009 | 1.90 | 1.95 |
| Dec 31, 2008 | 0.95 | 1.66 |
| Dec 31, 2007 | 2.33 | 1.74 |
| Dec 31, 2006 | 1.91 | 1.65 |
| Dec 31, 2005 | 1.89 | 1.82 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Eli Lilly & Co., current ratio, long-term trends, comparison to industry (health care)
| Eli Lilly & Co. | Health Care | |
|---|---|---|
| Dec 31, 2023 | 0.94 | 1.13 |
| Dec 31, 2022 | 1.05 | 1.15 |
| Dec 31, 2021 | 1.23 | 1.21 |
| Dec 31, 2020 | 1.40 | 1.20 |
| Dec 31, 2019 | 1.16 | 1.33 |
| Dec 31, 2018 | 1.73 | 1.37 |
| Dec 31, 2017 | 1.32 | 1.46 |
| Dec 31, 2016 | 1.37 | 1.67 |
| Dec 31, 2015 | 1.53 | 1.66 |
| Dec 31, 2014 | 1.09 | 1.87 |
| Dec 31, 2013 | 1.47 | 1.93 |
| Dec 31, 2012 | 1.55 | 1.81 |
| Dec 31, 2011 | 1.60 | 1.92 |
| Dec 31, 2010 | 2.09 | 1.80 |
| Dec 31, 2009 | 1.90 | 1.75 |
| Dec 31, 2008 | 0.95 | 1.42 |
| Dec 31, 2007 | 2.33 | 1.51 |
| Dec 31, 2006 | 1.91 | 1.39 |
| Dec 31, 2005 | 1.89 | 1.64 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).